Clean Science and Technology Ltd
NSE:CLEAN

Watchlist Manager
Clean Science and Technology Ltd Logo
Clean Science and Technology Ltd
NSE:CLEAN
Watchlist
Price: 860.85 INR 2.24% Market Closed
Market Cap: ₹91.5B

Clean Science and Technology Ltd
Investor Relations

In the bustling arena of specialty chemicals, Clean Science and Technology Ltd. has carved a unique niche for itself, emerging as a significant player known for its innovation and environmental consciousness. Founded in 2003, the company started with the vision of employing novel catalytic manufacturing processes that are not only energy-efficient but also environmentally friendly. Situated in the industrial heart of India, Pune, Clean Science capitalizes on its cutting-edge research and development capabilities to produce critical raw materials and intermediates. These products cater to a diverse range of industries such as pharmaceuticals, agrochemicals, and personal care. The company’s focus on green chemistry and cost-effective production methods has allowed it to rise above the competition, demonstrating how sustainability can be a formidable pillar of business strategy.

Clean Science and Technology’s business model hinges on an integrated, end-to-end production framework. By using proprietary technologies, it maintains tight control over its supply chain, ensuring high-quality standards while optimizing costs. The company profits primarily by supplying its products worldwide, leveraging an expansive export network that taps into high-demand markets across Asia, Europe, and North America. By innovating processes like vapour-phase hydrogenation and patented eco-friendly catalysts, Clean Science not only reduces its environmental footprint but also enhances profit margins through reduced waste and lower raw material consumption. As a result, their product lineup includes specialty chemicals like performance chemicals, pharmaceutical intermediates, and FMCG chemicals, all of which are high-margin segments with robust and growing global demand, ensuring their continued financial health and operational success.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Nov 6, 2025
AI Summary
Q2 2026

Revenue Decline: Standalone revenue fell 5% sequentially and 8% year-on-year to INR 206 crore, mainly due to weaker sales in established products.

Margin Resilience: Standalone EBITDA margin held steady at 44%, up 2% year-on-year thanks to a favorable product mix, though EBITDA and PAT both fell due to lower sales and forex losses.

HALS Growth: HALS segment saw strong volume growth (up 25% QoQ) and margin improvement, with higher-grade products being commercialized and exports gaining momentum.

CapEx & New Products: Around INR 150 crore invested in the first half; Performance Chemical 1 is undergoing chemical trials and is expected to be commercialized soon, with ramp-up targeted over the next three years.

Challenging Outlook: Management cited ongoing uncertainty from tariffs and demand issues, especially related to China and the US, and refrained from giving full-year EBITDA guidance.

Q4 Recovery Expected: Volume growth and new product contributions are expected to pick up in Q4, with Q3 likely to be flat.

Key Financials
Standalone Revenue
INR 206 crore
Standalone EBITDA
INR 90 crore
Standalone EBITDA Margin
44%
Standalone PAT
INR 65 crore
Consolidated Revenue
INR 240 crore
Consolidated EBITDA
INR 87 crore
Consolidated PAT
INR 55 crore
HALS Monthly Volume Run Rate
260 tonnes per month
HALS Material Margin
35%
CapEx (First Half)
INR 150 crore
Other Earnings Calls

Management

Mr. Ashok Ramnarayan Boob
Promoter, MD & Executive Director
No Bio Available
Mr. KrishnaKumar Ramnarayan Boob
Promotor & Whole-time Director
No Bio Available
Mr. Siddharth Ashok Sikchi
Promoter & Executive Director
No Bio Available
Mr. Krishnakumar Satyanarain Saboo
President
No Bio Available
Mr. Sanjay Wamanrao Parnerkar
Chief Financial Officer
No Bio Available
Mr. Vijay Jadhav
General Manager of Operations
No Bio Available
Mr. Pratik Abhaykumar Bora
Vice President of Corporate Finance
No Bio Available
Ms. Ruchita Kumar Vij B.Com, CS
Company Secretary & Compliance Officer
No Bio Available
Mubina Baber
Head of Human Resource
No Bio Available
Mr. Parth Ashok Maheshwari
President of Projects and Operations & Whole-Time Director
No Bio Available

Contacts

Address
MAHARASHTRA
Pune
Pentagon Tower 4, Magarpatta City, Hadapsar, Office No 503 5th Floor
Contacts